# Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty

> **NCT00827346** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 100 (estimated)

## Conditions studied

- Platelet Reactivity

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00827346
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827346, "Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00827346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*